Ved bekræftelse skal behandlingen afbrydes, og aminotransferaseniveauer monitoreres mindst hver fjortende dag, indtil niveauerne normaliseres.
Confirm by another liver test; if confirmed, stop treatment and monitor aminotransferase levels at least every 2 weeks until levels have normalised.